Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Sep;25(3):810–819. doi: 10.1128/iai.25.3.810-819.1979

Role of Rabbit Lysozyme in In Vitro Serum and Plasma Serum Bactericidal Reactions Against Bacillus subtilis

Stephen F Carroll 1, Rafael J Martinez 1
PMCID: PMC414520  PMID: 115789

Abstract

The antibacterial activity of purified rabbit lysozyme was kinetically investigated at concentrations comparable to those in normal rabbit serum and plasma serum. The bactericidal capability, lysozyme content, and electrophoretic composition of “purified β-lysin,” fractionated from normal rabbit serum, were also examined. In contrast to the extensive antibacterial activity of dilute normal rabbit serum observed in vitro, rabbit lysozyme was only weakly bactericidal for Bacillus subtilis. Inhibition of lysozyme enzymatic and bactericidal activities in normal rabbit serum by antilysozyme immunoglobulin G slightly reduced the initial rate of killing. The addition of neutralizing antibody or histamine (another lysozyme inhibitor) to partially purified bactericidal serum fractions had no effect on killing kinetics. Increasing the ionic strength of reaction mixtures containing normal serum or partially purified bactericidal fractions to levels which completely inhibited lysozyme activity resulted in stimulation of their respective killing kinetics. The addition of inhibitors to normal rabbit plasma serum completely eliminated its bactericidal activity. With regard to the killing of B. subtilis by rabbit and human blood fractions, these analyses clearly demonstrated that (i) although lysozyme is not a significant antibacterial component of normal rabbit serum, it represents the principal factor in normal rabbit plasma serum; (ii) different primary bactericidal mechanisms which are not detectable by singlepoint analyses operate in the sera of different species; and (iii) purified β-lysin isolated from normal rabbit serum by the classical procedure is a heterogenous mixture of components.

Full text

PDF
810

Images in this article

813Image
on p.813

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atassi M. Z., Habeeb A. F., Ando K. Enzymic and immunochemical properties of lysozyme. VII. Location of all the antigenic reactive regions. A new approach to study immunochemistry of tight proteins. Biochim Biophys Acta. 1973 Mar 23;303(1):203–209. [PubMed] [Google Scholar]
  2. BRUMFITT W., WARDLAW A. C., PARK J. T. Development of lysozyme-resistance in Micrococcus lysodiekticus and its association with an increased O-acetyl content of the cell wall. Nature. 1958 Jun 28;181(4626):1783–1784. doi: 10.1038/1811783a0. [DOI] [PubMed] [Google Scholar]
  3. Carroll S. F., Martinez R. J. Purification and properties of rabbit alveolar macrophage lysozyme. Infect Immun. 1979 May;24(2):460–467. doi: 10.1128/iai.24.2.460-467.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. DONALDSON D. M., ELLSWORTH B., MATHESON A. SEPARATION AND PURIFICATION OF BETA-LYSIN FROM NORMAL SERUM. J Immunol. 1964 Jun;92:896–901. [PubMed] [Google Scholar]
  5. DONALDSON D. M., MARCUS S. Studies on serum bactericidal activity; interrelationships of heparin, citrate, protamine and xirradiation on serum and plasma bactericidal activity against Bacillus subtilis. J Immunol. 1958 Oct;81(4):292–296. [PubMed] [Google Scholar]
  6. Feingold D. S., Goldman J. N., Kuritz H. M. Locus of the action of serum and the role of lysozyme in the serum bactericidal reaction. J Bacteriol. 1968 Dec;96(6):2118–2126. doi: 10.1128/jb.96.6.2118-2126.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Glazer A. N., Barel A. O., Howard J. B., Brown D. M. Isolation and characterization of fig lysozyme. J Biol Chem. 1969 Jul 10;244(13):3583–3589. [PubMed] [Google Scholar]
  8. Glynn A. A. The complement lysozyme sequence in immune bacteriolysis. Immunology. 1969 Apr;16(4):463–471. [PMC free article] [PubMed] [Google Scholar]
  9. HIRSCH J. G. Comparative bactericidal activities of blood serum and plasma serum. J Exp Med. 1960 Jul 1;112:15–22. doi: 10.1084/jem.112.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hayashi H., Araki Y., Ito E. Occurrence of glucosamine residues with free amino groups in cell wall peptidoglycan from bacilli as a factor responsible for resistance to lysozyme. J Bacteriol. 1973 Feb;113(2):592–598. doi: 10.1128/jb.113.2.592-598.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Howard J. B., Glazer A. N. Papaya lysozyme. Terminal sequences and enzymatic properties. J Biol Chem. 1969 Mar 25;244(6):1399–1409. [PubMed] [Google Scholar]
  12. JACOX R. F. The activation effect of calcium on a bactericidal substance for Bacillus subtilis in human serum. J Exp Med. 1950 Aug;92(2):101–111. doi: 10.1084/jem.92.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. MYRVIK Q. N., SOTO-FIGUEROA E., NAFF G., HENELT E. Studies on antibacterial factors in mammalian tissues and fluids. II. Cofactor requirements of a serum bactericidin for Bacillus subtilis. J Immunol. 1958 Aug;81(2):118–122. [PubMed] [Google Scholar]
  15. MYRVIK Q. N., WEISER R. S., KELLY M. C. Studies on the mode of action of lysozyme on Mycobacteria. Am Rev Tuberc. 1953 Oct;68(4):564–574. doi: 10.1164/art.1953.68.4.564. [DOI] [PubMed] [Google Scholar]
  16. MYRVIK Q. N., WEISER R. S. Studies on antibacterial factors in mammalian tissues and fluids. I. A serum bactericidin for Bacillus subtilis. J Immunol. 1955 Jan;74(1):9–16. [PubMed] [Google Scholar]
  17. Martinez R. J. Bactericidal properties of human cell-free lymph. Infect Immun. 1976 Mar;13(3):768–775. doi: 10.1128/iai.13.3.768-775.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Matheson A., Donaldson D. M. Effect of beta-lysin on isolated cell walls and protoplasts of Bacillus subtilis. J Bacteriol. 1970 Jan;101(1):314–317. doi: 10.1128/jb.101.1.314-317.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. OSHIMA S., MYRVIK Q. N., LEAKE E. The demonstration of lysozyme as a dominant tuberculostatic factor in extracts of granulomatous lungs. Br J Exp Pathol. 1961 Apr;42:138–144. [PMC free article] [PubMed] [Google Scholar]
  20. Osserman E. F., Lawlor D. P. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med. 1966 Nov 1;124(5):921–952. doi: 10.1084/jem.124.5.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Praissman M., Rupley J. A. Comparison of proteinstructure in the crystal and in solution. 3. Tritium-hydrogen exchange of lysozyme and a lysozyme-saccharide complex. Biochemistry. 1968 Jun;7(6):2446–2450. doi: 10.1021/bi00846a053. [DOI] [PubMed] [Google Scholar]
  22. Prieur D. J., Olson H. M., Young D. M. Lysozyme deficiency-an inherited disorder of rabbits. Am J Pathol. 1974 Nov;77(2):283–298. [PMC free article] [PubMed] [Google Scholar]
  23. Saint-Blancard J., Chuzel P., Mathieu Y., Perrot J., Jollès P. Influence of pH and ionic strength of the lysis of Micrococcus lysodeikticus cells by six human and four avian lysozymes. Biochim Biophys Acta. 1970 Nov 11;220(2):300–306. doi: 10.1016/0005-2744(70)90014-8. [DOI] [PubMed] [Google Scholar]
  24. Selsted M. E., Martinez R. J. Lysozyme: primary bactericidin in human plasma serum active against Bacillus subtilis. Infect Immun. 1978 Jun;20(3):782–791. doi: 10.1128/iai.20.3.782-791.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shinitzky M., Katchalski E., Grisaro V., Sharon N. Inhibition of lysozyme by imidazole and indole derivatives. Arch Biochem Biophys. 1966 Sep 26;116(1):332–343. doi: 10.1016/0003-9861(66)90039-7. [DOI] [PubMed] [Google Scholar]
  26. Shultz L. D., Wilder M. S. Fate of listeria monocytogenes in normal rabbit serum. Infect Immun. 1973 Feb;7(2):289–297. doi: 10.1128/iai.7.2.289-297.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Spizizen J. TRANSFORMATION OF BIOCHEMICALLY DEFICIENT STRAINS OF BACILLUS SUBTILIS BY DEOXYRIBONUCLEATE. Proc Natl Acad Sci U S A. 1958 Oct 15;44(10):1072–1078. doi: 10.1073/pnas.44.10.1072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Strominger J. L., Ghuysen J. M. Mechanisms of enzymatic bacteriaolysis. Cell walls of bacteri are solubilized by action of either specific carbohydrases or specific peptidases. Science. 1967 Apr 14;156(3772):213–221. doi: 10.1126/science.156.3772.213. [DOI] [PubMed] [Google Scholar]
  29. Weksler B. B., Nachman R. L. Rabbit platelet bactericidal protein. J Exp Med. 1971 Nov 1;134(5):1114–1130. doi: 10.1084/jem.134.5.1114. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES